GlassScriptPhysician profile
Stephen H King
NPI 1891897468
$9,288.99
in general payments reported to CMS, 2019-2025
50 companies · $2,554 in 2025
The $2,554 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,120 · 2020: $301 · 2021: $987 · 2022: $1,199 · 2023: $1,370 · 2024: $1,758 · 2025: $2,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,161 · Travel and Lodging: $267 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,160.88 |
| Travel and Lodging | $267.25 |
| Education | $253.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,041.51 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $661.43 | 2019-2025 | Provenge |
| Procept Biorobotics Corporation | $647.24 | 2019-2025 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $501.61 | 2019-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $428.37 | 2021-2025 | Urolift |
| Sumitomo Pharma America, INC. | $409.22 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $400.37 | 2019-2025 | |
| Abbvie INC. | $389.36 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $380.80 | 2021-2025 | Prolaris, Myrisk |
| Boston Scientific Corporation | $322.52 | 2019-2025 | Advantage System, Rezum Generator, Lithovue |
| Bayer Healthcare Pharmaceuticals INC. | $315.49 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $272.48 | 2023-2025 | Lynparza, Keytruda, Welireg |
| Coloplast Corp | $246.84 | 2019-2025 | |
| Urogen Pharma, INC. | $215.97 | 2021-2025 | Jelmyto |
| Endo USA, INC. | $207.61 | 2024-2025 | Xiaflex, Aveed |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $189.85 | 2024-2025 | |
| Rochester Medical Corporation | $189.46 | 2021-2022 | |
| Aerin Medical INC. | $171.20 | 2025 | |
| Sun Pharmaceutical Industries INC. | $164.43 | 2019-2024 | Yonsa |
| Progenics Pharmaceuticals, INC. | $159.72 | 2021-2025 | Pylarify |
| Antares Pharma, INC. | $155.66 | 2019-2025 | Xyosted |
| 180 Medical, INC. | $137.79 | 2021-2024 | Cure Ultra Catheter, Gentlecath |
| C. R. Bard, INC. & Subsidiaries | $134.16 | 2019-2025 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $130.82 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $121.31 | 2023-2025 | Trelstar |
| Axonics, INC. | $119.67 | 2022-2024 | Axonics |
| Tolmar Pharmaceuticals, INC. | $117.22 | 2019-2022 | |
| Convatec INC. | $107.88 | 2022-2025 | |
| Accord Healthcare, INC. | $100.24 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $79.46 | 2019-2023 | Xiaflex |
| Valencia Technologies Corporation | $79.20 | 2025 | Ecoin Device Kit |
| Urovant Sciences INC | $74.46 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $74.19 | 2019-2024 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $72.85 | 2021-2025 | Lynparza |
| Laborie Medical Technologies Corp. | $65.98 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $62.38 | 2025 | Itind System |
| Amgen INC. | $58.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $52.36 | 2025 | |
| Tolmar, INC. | $44.15 | 2023 | |
| Calyxo, INC. | $21.15 | 2024 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $20.45 | 2023 | |
| Telix Pharmaceuticals | $20.17 | 2024 | Illuccix |
| Agiliti Surgical, INC. | $18.41 | 2024 | Sonablate Hifu |
| Baxter Healthcare | $17.71 | 2023 | Tisseel |
| Medtronic USA, INC. | $17.31 | 2019 | |
| Karl Storz Endoscopy-America | $16.39 | 2025 | |
| Profound Medical Corp. | $15.91 | 2025 | Tulsa-Pro |
| Allergan, INC. | $15.58 | 2019 | |
| Travere Therapeutics, INC. | $11.82 | 2019-2020 | |
| Amniox Medical, INC. | $10.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.